Ravi Salgia to Lymphoma, Non-Hodgkin
This is a "connection" page, showing publications Ravi Salgia has written about Lymphoma, Non-Hodgkin.
Connection Strength
0.379
-
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma. Target Oncol. 2012 Sep; 7(3):199-210.
Score: 0.369
-
BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration. Blood. 2000 Dec 15; 96(13):4328-34.
Score: 0.010